PCSK9 and hyperlipidemia: Overexpression of PCSK9 in atherosclerotic murine models showed that the PCSK9-mediated pro-atherosclerotic impact is LDLR-dependent, highlighting the importance of PCSK9 in LDLR expression and subsequent hyperlipidemia [13].